Drug name - Savella
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6602911 | ALLERGAN | Methods of treating fibromyalgia |
Jan, 2023
(3 months from now) | |
| US7994220 | ALLERGAN | Milnacipran for the long-term treatment of fibromyalgia syndrome |
Sep, 2029
(6 years from now) | |
Drugs and Companies using MILNACIPRAN HYDROCHLORIDE ingredient
Treatment: Management of fibromyalgia (fm); Management of fibromyalgia
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 12.5MG | TABLET;ORAL | Prescription |
| 25MG | TABLET;ORAL | Prescription |
| 50MG | TABLET;ORAL | Prescription |
| 100MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.